Article
[Mechanism of acquired antiestrogen resistance and its management in breast cancer].
Nihon rinsho. Japanese journal of clinical medicine - 1 May 1997
Iino Y, Maemura M, Morishita Y
Abstract excerpt
Although non-steroidal antiestrogen, tamoxifen(TAM), has been known to be useful for estrogen receptor(ER)-positive breast cancer, acquired tamoxifen resistance frequently occurs during the treatment. Several factors seem to be responsible for the resistance; decreased level of ER, mutation of ER, agonistic effect of TAM, ovarian steroidogenesis, altered metabolism of TAM, and increased expression level of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
